Immunotherapy targeting intracellular pathogens

Details Immunotherapy targeting intracellular pathogens Immunotherapy targeting intracellular pathogens

A - Human Necessities

61

K

A61K 39/385 (2006.01)

Patent

CA 2715611

The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from an intracellular pathogen-associated antigen and a redox motif such as C-(X)2-[CST] or [CST]- (X)2-C in the prevention and/or treatment of infection with an intracellular pathogen and in the manufacture of medicaments therefore.

La présente invention concerne l'utilisation de peptides immunogènes comprenant un épitope de lymphocyte T dérivé d'un antigène associé à un agent pathogène intracellulaire et un motif redox tel que C-(X)2-[CST] ou [CST]-(X)2-C, d'une part pour la prévention et/ou le traitement d'une infection par un agent pathogène intracellulaire, et d'autre part pour la fabrication de médicaments à cet effet.

Affiliated with

Also associated with

Rating

Immunotherapy targeting intracellular pathogens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapy targeting intracellular pathogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapy targeting intracellular pathogens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1584232